Suchergebnisse - "Shih, Shin-Ru"

PubPharm (376)

21

Emergence and Persistent Dominance of Omicron BA.2.3.7 Variant in Community Outbreaks in Taiwan

enthalten in: bioRxiv.org | 2023

von Shao, P. | Tu, H. | Gong, Y. | +18

22

Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines

enthalten in: Microbes and infection | 2023

von Kung, Y. | Huang, S. | Huang, C. | +13

23

Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19 : A single-blinded, randomized clinical trial

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2022

von Chuang, C. | Huang, C. | Huang, C. | +10

24

Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19

enthalten in: bioRxiv.org | 2022

von Kuo, T. | Lin, M. | Coffman, R. | +12

25

Anti-spike antibody response to natural infection with SARS-CoV-2 and its activity against emerging variants

enthalten in: bioRxiv.org | 2022

von Chen, C. | Huang, K. | Shih, S. | +5

26

The Bottlenecks of Preparing Virus Particles by Size Exclusion for Antibody Generation

enthalten in: International journal of molecular sciences | 2022

von Lee, C. | Huang, P. | Mwale, P. | +11

27

A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19

enthalten in: Nature communications | 2022

von Chen, C. | Yang, L. | Chang, W. | +5

28

Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants

enthalten in: Microbiology spectrum | 2022

von Chen, C. | Huang, K. | Shih, S. | +5

29

Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901 : An Extension to an Open-Label, Dose-Escalation Phase 1 Study

enthalten in: Infectious diseases and therapy | 2022

von Hsieh, S. | Chang, S. | Cheng, H. | +2

30

Titers and capacity of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: a single-blinded, randomized clinical trial

enthalten in: bioRxiv.org | 2022

von Chuang, C. | Huang, C. | Huang, C. | +10